Table 1.

Patientdemographic and baseline characteristics

Characteristic	N=35
Age, median (range), years	63 (35–84)
ECOG PS (0, 1, 2)	16 (46%), 17 (49%), 2 (6%)
Male, n (%)	31 (89)
Histology, n (%)
Papillary	19 (54)
Chromophobe	6 (17)
Unclassified	10 (29)
IMDC risk category, n (%)
Favorable	8 (23)
Intermediate	18 (51)
Poor	9 (26)
Sarcomatoid features	9 (26)
PD-L1 status—missing	6 (17)
%+ (0, 1–5, 5–20,>20)	14 (40), 4 (11), 3 (9), 8 (23)

ECOG, Eastern Cooperative Oncology Group; IMDC, International Metastatic RCC Database Consortium; PD-L1, programmed death ligand 1; PS, performance status.